351 related articles for article (PubMed ID: 29514829)
1. Expression of Organic Anion Transporter 1 or 3 in Human Kidney Proximal Tubule Cells Reduces Cisplatin Sensitivity.
Nieskens TTG; Peters JGP; Dabaghie D; Korte D; Jansen K; Van Asbeck AH; Tavraz NN; Friedrich T; Russel FGM; Masereeuw R; Wilmer MJ
Drug Metab Dispos; 2018 May; 46(5):592-599. PubMed ID: 29514829
[TBL] [Abstract][Full Text] [Related]
2. A Human Renal Proximal Tubule Cell Line with Stable Organic Anion Transporter 1 and 3 Expression Predictive for Antiviral-Induced Toxicity.
Nieskens TT; Peters JG; Schreurs MJ; Smits N; Woestenenk R; Jansen K; van der Made TK; Röring M; Hilgendorf C; Wilmer MJ; Masereeuw R
AAPS J; 2016 Mar; 18(2):465-75. PubMed ID: 26821801
[TBL] [Abstract][Full Text] [Related]
3. Prediction of clinical drug-drug interactions of veliparib (ABT-888) with human renal transporters (OAT1, OAT3, OCT2, MATE1, and MATE2K).
Kikuchi R; Lao Y; Bow DA; Chiou WJ; Andracki ME; Carr RA; Voorman RL; De Morais SM
J Pharm Sci; 2013 Dec; 102(12):4426-32. PubMed ID: 24122511
[TBL] [Abstract][Full Text] [Related]
4. Organic anion transporters 1 and 3 influence cellular energy metabolism in renal proximal tubule cells.
Vriend J; Hoogstraten CA; Venrooij KR; van den Berge BT; Govers LP; van Rooij A; Huigen MCDG; Schirris TJJ; Russel FGM; Masereeuw R; Wilmer MJ
Biol Chem; 2019 Sep; 400(10):1347-1358. PubMed ID: 30653465
[TBL] [Abstract][Full Text] [Related]
5. Precise comparison of protein localization among OCT, OAT, and MATE in human kidney.
Motohashi H; Nakao Y; Masuda S; Katsura T; Kamba T; Ogawa O; Inui K
J Pharm Sci; 2013 Sep; 102(9):3302-8. PubMed ID: 23630107
[TBL] [Abstract][Full Text] [Related]
6. A Multicompartment Human Kidney Proximal Tubule-on-a-Chip Replicates Cell Polarization-Dependent Cisplatin Toxicity.
Nieskens TTG; Persson M; Kelly EJ; Sjögren AK
Drug Metab Dispos; 2020 Dec; 48(12):1303-1311. PubMed ID: 33020068
[TBL] [Abstract][Full Text] [Related]
7. Renal uptake of substrates for organic anion transporters Oat1 and Oat3 and organic cation transporters Oct1 and Oct2 is altered in rats with adenine-induced chronic renal failure.
Komazawa H; Yamaguchi H; Hidaka K; Ogura J; Kobayashi M; Iseki K
J Pharm Sci; 2013 Mar; 102(3):1086-94. PubMed ID: 23280877
[TBL] [Abstract][Full Text] [Related]
8. Screening of Drug-Transporter Interactions in a 3D Microfluidic Renal Proximal Tubule on a Chip.
Vriend J; Nieskens TTG; Vormann MK; van den Berge BT; van den Heuvel A; Russel FGM; Suter-Dick L; Lanz HL; Vulto P; Masereeuw R; Wilmer MJ
AAPS J; 2018 Jul; 20(5):87. PubMed ID: 30051196
[TBL] [Abstract][Full Text] [Related]
9. Transporter studies with the 3-O-sulfate conjugate of 17alpha-ethinylestradiol: assessment of human kidney drug transporters.
Han YH; Busler D; Hong Y; Tian Y; Chen C; Rodrigues AD
Drug Metab Dispos; 2010 Jul; 38(7):1064-71. PubMed ID: 20360303
[TBL] [Abstract][Full Text] [Related]
10. Renal tubular secretion of tanshinol: molecular mechanisms, impact on its systemic exposure, and propensity for dose-related nephrotoxicity and for renal herb-drug interactions.
Jia W; Du F; Liu X; Jiang R; Xu F; Yang J; Li L; Wang F; Olaleye OE; Dong J; Li C
Drug Metab Dispos; 2015 May; 43(5):669-78. PubMed ID: 25710938
[TBL] [Abstract][Full Text] [Related]
11. Interaction of immunosuppressive drugs with human organic anion transporter (OAT) 1 and OAT3, and multidrug resistance-associated protein (MRP) 2 and MRP4.
El-Sheikh AA; Greupink R; Wortelboer HM; van den Heuvel JJ; Schreurs M; Koenderink JB; Masereeuw R; Russel FG
Transl Res; 2013 Dec; 162(6):398-409. PubMed ID: 24036158
[TBL] [Abstract][Full Text] [Related]
12. Tenofovir alafenamide is not a substrate for renal organic anion transporters (OATs) and does not exhibit OAT-dependent cytotoxicity.
Bam RA; Yant SR; Cihlar T
Antivir Ther; 2014; 19(7):687-92. PubMed ID: 24699134
[TBL] [Abstract][Full Text] [Related]
13. Sex differences in the mRNA, protein, and functional expression of organic anion transporter (Oat) 1, Oat3, and organic cation transporter (Oct) 2 in rabbit renal proximal tubules.
Groves CE; Suhre WB; Cherrington NJ; Wright SH
J Pharmacol Exp Ther; 2006 Feb; 316(2):743-52. PubMed ID: 16249371
[TBL] [Abstract][Full Text] [Related]
14. Role of organic cation transporter OCT2 and multidrug and toxin extrusion proteins MATE1 and MATE2-K for transport and drug interactions of the antiviral lamivudine.
Müller F; König J; Hoier E; Mandery K; Fromm MF
Biochem Pharmacol; 2013 Sep; 86(6):808-15. PubMed ID: 23876341
[TBL] [Abstract][Full Text] [Related]
15. Cetuximab Prevents Methotrexate-Induced Cytotoxicity in Vitro through Epidermal Growth Factor Dependent Regulation of Renal Drug Transporters.
Caetano-Pinto P; Jamalpoor A; Ham J; Goumenou A; Mommersteeg M; Pijnenburg D; Ruijtenbeek R; Sanchez-Romero N; van Zelst B; Heil SG; Jansen J; Wilmer MJ; van Herpen CML; Masereeuw R
Mol Pharm; 2017 Jun; 14(6):2147-2157. PubMed ID: 28493713
[TBL] [Abstract][Full Text] [Related]
16. Mirogabalin, a novel α
Yamamura N; Mikkaichi T; Itokawa KI; Hoshi M; Damme K; Geigner S; Baumhauer C
Xenobiotica; 2022; 52(9-11):997-1009. PubMed ID: 36170033
[TBL] [Abstract][Full Text] [Related]
17. Relative contribution of OAT and OCT transporters to organic electrolyte transport in rabbit proximal tubule.
Zhang X; Groves CE; Bahn A; Barendt WM; Prado MD; Rödiger M; Chatsudthipong V; Burckhardt G; Wright SH
Am J Physiol Renal Physiol; 2004 Nov; 287(5):F999-1010. PubMed ID: 15251863
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of
Parvez MM; Shin HJ; Jung JA; Shin JG
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223391
[No Abstract] [Full Text] [Related]
19. Assessment of vandetanib as an inhibitor of various human renal transporters: inhibition of multidrug and toxin extrusion as a possible mechanism leading to decreased cisplatin and creatinine clearance.
Shen H; Yang Z; Zhao W; Zhang Y; Rodrigues AD
Drug Metab Dispos; 2013 Dec; 41(12):2095-103. PubMed ID: 24026623
[TBL] [Abstract][Full Text] [Related]
20. The Use of Transporter Probe Drug Cocktails for the Assessment of Transporter-Based Drug-Drug Interactions in a Clinical Setting-Proposal of a Four Component Transporter Cocktail.
Ebner T; Ishiguro N; Taub ME
J Pharm Sci; 2015 Sep; 104(9):3220-8. PubMed ID: 25981193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
